Depending on dose, firmonertinib shrank tumors in 43% to 68% of patients as a first treatment for EGFR PACC-mutant lung cancer in the phase 1b FURTHER trial.
|Articles|March 8, 2021
7 Recent News and Updates in Lung Cancer
Author(s)Ryan McDonald
A roundup of some of the latest news and updates for patients with lung cancer from CURE®.
Advertisement
There have been many updates in the field of lung cancer over the past several weeks. Here, CURE® looks back at some of the latest news and updates in lung cancer that patients and survivors may have missed.
- Keytruda monotherapy continued to significantly improve overall and progression-free survival in patients with previously treated, PD-L1–positive advanced non-small cell lung cancer.
READ MORE . - Recent study results demonstrated that an at-home prehabilitation program may improve surgical outcomes in patients with lung cancer.
READ MORE .
- Treatment with sotorasib, a KRAS G12C inhibitor, induced rapid responses and encouraging survival outcomes in previously treated patients with KRAS G12C–mutated advanced non–small cell lung cancer.
READ MORE . - Treatment with Opdivo (nivolumab) plus Yervoy (ipilimumab) and two cycles of platinum doublet chemotherapy in the front-line setting was associated with a significant improvement in overall survival in patients with advanced non-small cell lung cancer, compared to treatment with chemotherapy alone.
READ MORE . - The International Association for the Study of Lung Cancer recently joined more than 100 cancer centers and organizations in requesting that leading public health officials, President Joseph Biden and other members of the administration prioritize the delivery of a COVID-19 vaccine to cancer survivors and patients receiving active treatment.
READ MORE . - Findings from a study focused on patient-reported experiences, found that aching joints, aching muscles and fatigue were more common than initially found in clinical trials.
READ MORE . - Study results demonstrated that the immunotherapy Tecentriq (atezolizumab) plus carboplatin and etoposide safely improved overall survival in patients with extensive-stage small-cell lung cancer.
READ MORE .
For more news on cancer updates, research and education, don’t forget to
Advertisement
Related to this article
U.S. counties where more residents had medical debt in collections had higher rates of late-stage lung, head and neck, colorectal and several other cancers, according to a study of 2,958 counties published in October 2026 in JAMA Network Open.
Libtayo survival data, a rare positive osteosarcoma trial and new ADCs for breast, lung and stomach cancers are among ESMO 2026 abstracts to watch.
Patients with a newly identified tumor state had shorter survival following chemotherapy and immunotherapy, potentially helping doctors identify those at greater risk of poor outcomes.
Learn why hepatitis B can reactivate during cancer treatment, which therapies increase the risk and how antiviral medicines can help protect liver health.
After her sister’s Hodgkin lymphoma diagnosis, remission and relapse, a caregiver reflects on follow-up care, guilt and finding hope between cancer battles.
After a pancreatic cancer diagnosis upended his life and career, one survivor reflects on treatment, resilience and finding hope more than a decade later.
The American Society of Hematology published 2026 guidelines for adults with myelofibrosis on Oct. 14, 2026, with 10 recommendations on genetic testing, JAK inhibitors, anemia, transplant referral and aspirin.
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Jemperli for dMMR Locally Advanced Rectal Cancer
2
New Myelofibrosis Guidelines Back Wider Gene Testing at Diagnosis
3
Gemcitabine Plus BCG Clears Bladder Cancer in 96% of Patients After BCG Failure
4
FDA Clears AI Tool Using MRI to Gauge Breast Cancer Recurrence
5